Insulin resistance means the body’s cells do not respond to insulin as well as expected. Insulin is a hormone that helps move glucose from the bloodstream into cells for energy. When the body becomes more resistant to insulin, the pancreas may make more insulin to keep blood sugar in range. Over time, blood sugar may rise into prediabetes or type 2 diabetes.
Insulin resistance is not measured by one number in everyday care. Instead, clinicians often look at a pattern of metabolic markers: blood glucose, A1C, triglycerides, HDL cholesterol, blood pressure, waist size, liver markers, weight changes, and other risk factors. Understanding these markers can make follow-up visits more useful.
This guide explains the key metabolic markers to understand with insulin resistance, what each one can and cannot tell you, and when results should prompt medical follow-up.
Why Metabolic Markers Matter
CDC explains that insulin resistance can lead to prediabetes and type 2 diabetes, and that insulin is a key hormone that regulates blood sugar. CDC also notes that people do not have to have overweight or obesity to have insulin resistance.
NIDDK describes metabolic syndrome as a group of conditions that can include high blood pressure and a large waist size and that increases risk for heart disease, diabetes, and stroke. NIDDK also notes that the levels of fat in the blood may rise with insulin resistance or prediabetes.
A useful insulin resistance discussion should answer four questions: Are blood sugar markers rising? Are cholesterol and triglyceride patterns changing? Is blood pressure increasing risk? Are waist size, liver health, sleep, activity, and family history part of the picture?
Marker 1: Fasting Plasma Glucose
Fasting plasma glucose is a blood test taken after not eating for a set period, usually overnight. It measures blood sugar at one point in time.
- Can help identify normal glucose, prediabetes, or diabetes ranges
- Can be affected by stress, illness, sleep, medications, and recent eating
- Does not show after-meal glucose spikes
- May need repeat testing or confirmation depending on the result
NIDDK lists fasting plasma glucose as one of the recommended tests used to identify prediabetes. NIDDK also notes that the risk for progression to type 2 diabetes becomes higher with more elevated test results.
Marker 2: A1C
A1C is a blood test that estimates average blood sugar over about the past 2 to 3 months. It is commonly used to screen for and monitor prediabetes and diabetes.
- Useful for longer-term glucose trends
- Does not show daily highs and lows
- May be affected by conditions that change red blood cell turnover
- Should be interpreted with symptoms, fasting glucose, risk factors, and clinical context
CDC explains that the A1C test measures average blood sugar over the past 2 to 3 months. NIDDK also notes that some conditions can affect A1C results, so clinicians may use other glucose tests when A1C is not reliable.
Marker 3: Oral Glucose Tolerance Test
An oral glucose tolerance test, or OGTT, measures how the body handles a glucose drink over time. It can sometimes show impaired glucose handling when fasting glucose or A1C are less clear.
- May help identify prediabetes or diabetes in selected situations
- Requires preparation and timed blood samples
- Can show how glucose responds after a challenge
- Is not usually done as casually as a basic fasting lab
NIDDK includes the oral glucose tolerance test among recommended tests for identifying prediabetes, along with fasting plasma glucose and A1C.
Marker 4: Fasting Insulin
Fasting insulin is sometimes ordered to understand how much insulin the body is producing while fasting. Higher insulin may suggest the body is working harder to keep glucose controlled, but interpretation is not as standardized as A1C or fasting glucose.
- May provide context in selected metabolic evaluations
- Can vary by lab, timing, and health status
- Is not usually the main diagnostic test for diabetes or prediabetes
- Should be interpreted by a clinician, not used alone
If fasting insulin is included in your lab panel, ask what the result changes about your care plan. It may be more useful when paired with fasting glucose, A1C, triglycerides, waist size, blood pressure, and clinical history.
Marker 5: Triglycerides
Triglycerides are a type of fat in the blood. Elevated triglycerides are common in insulin resistance and metabolic syndrome patterns.
- May rise with insulin resistance, high refined carbohydrate intake, excess alcohol, uncontrolled diabetes, some medications, thyroid disease, kidney disease, liver disease, and genetics
- Can be measured fasting or nonfasting depending on the clinician’s purpose
- Should be reviewed with HDL, LDL, non-HDL cholesterol, and overall heart risk
- Very high levels may require urgent attention because of pancreatitis risk
The ADA 2026 Standards of Care state that, for people with diabetes, clinicians should address lifestyle factors, secondary factors, and medications that raise triglycerides when fasting triglycerides are above 150 mg/dL or nonfasting triglycerides are above 175 mg/dL.
Marker 6: HDL Cholesterol
HDL cholesterol is often called “good” cholesterol because it is part of the body’s cholesterol transport system. Low HDL can appear in insulin resistance and metabolic syndrome patterns.
- Low HDL may occur alongside elevated triglycerides
- HDL should be interpreted with LDL, triglycerides, blood pressure, diabetes risk, smoking status, and family history
- Exercise, smoking cessation, nutrition, weight management when appropriate, and metabolic health may influence HDL patterns
- Raising HDL alone is not the whole goal; overall cardiovascular risk matters
NIDDK’s diabetes risk-factor guidance lists HDL cholesterol below 35 mg/dL and fasting triglycerides above 250 mg/dL among risk factors that can prompt diabetes testing in at-risk patients.
Marker 7: LDL and Non-HDL Cholesterol
LDL cholesterol and non-HDL cholesterol matter because insulin resistance often overlaps with cardiovascular risk. Even when glucose is only mildly elevated, heart-risk markers still deserve attention.
- LDL cholesterol is often a main treatment target for heart-risk reduction
- Non-HDL cholesterol can be useful when triglycerides are elevated
- Family history, diabetes, blood pressure, kidney disease, smoking, and age affect risk decisions
- Medication may be recommended for some people even when lifestyle changes are also important
For people with diabetes, the ADA Standards of Care include lipid management as part of cardiovascular risk reduction. Insulin resistance without diabetes should still prompt a broader heart-risk conversation when cholesterol, blood pressure, family history, or other risk factors are present.
Marker 8: Blood Pressure
Blood pressure is a key metabolic and cardiovascular marker. Insulin resistance often appears alongside higher blood pressure, especially when abdominal weight gain, sleep apnea, inactivity, high sodium intake, kidney disease, or family history are also present.
- Track clinic readings and home readings if recommended
- Record both systolic and diastolic numbers
- Note caffeine, pain, stress, exercise, sleep, and medication timing
- Ask what blood pressure goal fits your health history
NIDDK describes metabolic syndrome as including high blood pressure and large waist size among conditions that increase risk for heart disease, diabetes, and stroke.
Marker 9: Waist Circumference
Waist circumference can help estimate central adiposity, which is linked with insulin resistance and cardiometabolic risk. It is not a perfect measurement, but it can add useful context.
- Measure at the same location each time
- Use a flexible tape measure
- Measure after a normal exhale
- Track trends monthly rather than daily
- Interpret with BMI, muscle mass, ethnicity, age, and health history
NIDDK notes that BMI and waist size can help identify whether a person has overweight or obesity and whether they may have higher risk for related health problems.
Marker 10: Weight Trend and Body Composition
Weight trend can be useful, but it should not be the only marker. Some people with insulin resistance have higher body weight, while others do not. Muscle mass, waist size, activity level, sleep, genetics, medications, and liver health all matter.
- Track weight as a trend if appropriate for you
- Do not judge daily water shifts as fat gain or loss
- Pair weight with waist, strength, activity, sleep, and labs
- Ask for a less weight-focused plan if weighing increases distress or disordered eating
CDC notes that although overweight and obesity are risk factors for insulin resistance, a person does not have to have them to have insulin resistance.
Marker 11: Liver Enzymes and Fatty Liver Risk
Insulin resistance can overlap with metabolic dysfunction–associated steatotic liver disease, formerly often called fatty liver disease. Liver enzymes may be part of the evaluation, but normal enzymes do not always rule out liver fat or liver risk.
- ALT and AST may be checked on routine blood work
- Triglycerides, glucose, waist size, and weight history may add context
- Alcohol use, medications, viral hepatitis risk, and family history also matter
- Your clinician may order imaging or additional tests if needed
NIDDK notes that people who have insulin resistance, unhealthy levels of fat in the blood, metabolic syndrome, type 2 diabetes, and certain genes can develop NAFLD and NASH, now often described under updated liver disease terminology.
Marker 12: Kidney Function and Urine Albumin
Kidney markers are not specific tests for insulin resistance, but they matter when glucose, blood pressure, and cardiovascular risk are part of the picture.
- Creatinine and eGFR estimate kidney function
- Urine albumin-to-creatinine ratio can show early kidney stress in some people
- Blood pressure, diabetes, and some medications can affect kidney monitoring
- Kidney results can affect medication choices
Ask whether kidney testing is needed based on your blood pressure, glucose results, medication plan, diabetes status, family history, or other risk factors.
Marker 13: PCOS and Reproductive Clues
For some people, insulin resistance is connected with polycystic ovary syndrome, or PCOS. Reproductive symptoms can provide clues that metabolic testing is needed.
- Irregular periods
- Acne or excess facial or body hair
- Difficulty with ovulation or fertility
- History of gestational diabetes
- Weight changes or waist gain
The ADA 2026 Standards list polycystic ovary syndrome and other clinical conditions associated with insulin resistance among risk factors that can prompt diabetes or prediabetes testing in adults with overweight or obesity.
Marker 14: Skin and Physical Exam Clues
Some physical findings can suggest insulin resistance, though they do not diagnose it alone.
- Acanthosis nigricans, which may appear as darker, velvety skin in body folds
- Skin tags
- Central weight gain
- Signs of PCOS, such as acne or excess hair growth
The ADA 2026 Standards list severe obesity, acanthosis nigricans, and metabolic dysfunction–associated steatotic liver disease among clinical conditions associated with insulin resistance.
Marker 15: Sleep and Sleep Apnea Symptoms
Sleep affects glucose regulation, appetite, blood pressure, inflammation, and recovery. Sleep apnea can also overlap with insulin resistance, high blood pressure, and metabolic risk.
- Loud snoring
- Witnessed pauses in breathing
- Morning headaches
- Daytime sleepiness
- High blood pressure that is hard to control
If sleep apnea symptoms are present, ask whether evaluation is appropriate. Improving sleep quality may be part of a broader metabolic plan.
Marker 16: Medication and Health History Clues
Some medications and health conditions can affect glucose, weight, appetite, cholesterol, blood pressure, or liver markers.
- Steroids and some psychiatric medicines
- Certain HIV medicines or antiretroviral changes
- Thyroid disease
- Gestational diabetes history
- Family history of type 2 diabetes, early heart disease, or fatty liver disease
The ADA 2026 Standards include HIV-related screening recommendations and note that some conditions can affect the relationship between A1C and actual glucose, so plasma glucose criteria may be preferred in selected situations.
Which Markers Should You Track at Home?
Most metabolic markers require lab testing, but home tracking can support the conversation.
- Weekly or monthly: weight trend if appropriate, waist size, activity, sleep, energy, and symptoms
- If recommended: home blood pressure readings
- At visits or lab intervals: A1C, fasting glucose, lipid panel, liver enzymes, kidney function, and urine albumin if indicated
- Context: medication changes, illness, stress, sleep disruption, menstrual changes, and major lifestyle changes
Ask your clinician which markers matter most for your next 3 to 6 months. Tracking everything can be overwhelming; tracking the right few things is more useful.
What to Bring to a Clinician Visit
Bring a short summary that connects numbers with daily life.
- Recent A1C, fasting glucose, or oral glucose tolerance test results
- Lipid panel, including triglycerides, HDL, LDL, and total cholesterol
- Blood pressure readings if available
- Waist measurement or weight trend if you track them
- Medication and supplement list
- Family history of diabetes, heart disease, fatty liver disease, or PCOS
- Sleep, activity, nutrition, and stress patterns
- Questions about prediabetes, diabetes prevention, medication, nutrition, exercise, and follow-up testing
Ask what each result means, what target is realistic, when labs should be repeated, and what change would show progress.
Home Tools That May Help
Home tools can support insulin resistance tracking when used calmly and consistently. Helpful options may include a blood pressure monitor if recommended, scale if appropriate, tape measure, activity tracker, food pattern log, sleep log, medication organizer, lab-result folder, and symptom diary.
Some people use body composition monitors, but those estimates can be affected by hydration, meals, exercise, and device quality. Use them for trends only, not diagnosis.
Home tools should help you prepare for better visits, not create constant checking or fear.
Common Mistake: Focusing Only on Glucose
Glucose matters, but insulin resistance is often part of a broader metabolic pattern.
Triglycerides, HDL cholesterol, blood pressure, waist size, liver health, sleep, and activity can all add context.
Ask about the full cardiometabolic picture, not only one glucose result.
Common Mistake: Treating Fasting Insulin as a Stand-Alone Diagnosis
Fasting insulin can be interesting, but it is not the main standard diagnostic test for prediabetes or diabetes.
Do not make major decisions based on fasting insulin alone.
Interpret it with glucose, A1C, triglycerides, waist size, blood pressure, and clinical history.
Common Mistake: Ignoring Normal-Range Warning Patterns
Some markers may still be “normal” but moving in an unfavorable direction over time.
A rising A1C, rising waist size, rising triglycerides, falling HDL, or increasing blood pressure may deserve attention before diabetes develops.
Ask your clinician to compare trends, not only single results.
Common Mistake: Assuming Weight Explains Everything
Body weight can matter, but it is not the whole story. Some people with insulin resistance do not have obesity, and some people with higher body weight have different metabolic patterns.
Focus on labs, blood pressure, waist, activity, sleep, nutrition, medication history, and family history.
A useful plan should be personalized, not based only on the scale.
Common Mistake: Delaying Follow-Up Because You Feel Fine
Insulin resistance and prediabetes can be silent. Feeling fine does not always mean metabolic markers are stable.
CDC notes that prediabetes means blood sugar is higher than normal but not high enough for type 2 diabetes, and a blood test is needed to find out if you have prediabetes or diabetes.
Follow recommended testing intervals if you have risk factors.
When to Talk to a Clinician
Talk to a clinician if you have elevated fasting glucose, elevated A1C, high triglycerides, low HDL, high blood pressure, increasing waist size, fatty liver concerns, PCOS symptoms, history of gestational diabetes, sleep apnea symptoms, family history of type 2 diabetes, or symptoms such as increased thirst, frequent urination, unexplained weight change, fatigue, or blurred vision.
You should also seek guidance if lab results are confusing, if you are considering supplements or restrictive diets, if you have disordered eating concerns, or if medications may be affecting glucose, appetite, weight, blood pressure, or lipids.
A clinician may recommend repeat testing, A1C, fasting glucose, oral glucose tolerance testing, lipid panel, liver testing, kidney testing, blood pressure monitoring, sleep apnea evaluation, nutrition support, physical activity guidance, diabetes prevention programs, or medication in selected situations.
When to Seek Urgent or Emergency Care
Seek urgent or emergency care for chest pain or pressure, severe shortness of breath, fainting, stroke symptoms, severe weakness, confusion, severe dehydration, persistent vomiting, severe abdominal pain, or symptoms that feel life-threatening.
Seek prompt care for symptoms of very high blood sugar, such as extreme thirst, frequent urination, vomiting, abdominal pain, fruity breath, deep or rapid breathing, severe fatigue, or confusion.
Do not wait for a routine metabolic follow-up if symptoms suggest heart attack, stroke, severe hyperglycemia, dehydration, infection, or another emergency.
The Bottom Line
Insulin resistance is best understood through patterns, not one isolated number. Key metabolic markers include fasting glucose, A1C, oral glucose tolerance testing when used, fasting insulin in selected cases, triglycerides, HDL, LDL, non-HDL cholesterol, blood pressure, waist circumference, weight trend, liver enzymes, kidney markers, PCOS clues, skin findings, sleep apnea symptoms, medication history, and family history.
The most useful approach is to track trends over time and connect lab results with daily habits, symptoms, medications, sleep, activity, and cardiovascular risk.
The most common mistakes are focusing only on glucose, treating fasting insulin as a stand-alone diagnosis, ignoring normal-range warning patterns, assuming weight explains everything, and delaying follow-up because you feel fine.
Bring your lab results, home readings, medication list, and questions to your next visit. Ask which markers matter most for your health history, what changes would show progress, and when testing should be repeated.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, diabetes screening, prediabetes care, insulin resistance evaluation, nutrition therapy, medication management, lab interpretation, cardiovascular care, liver care, kidney care, or emergency care. Always consult your physician, endocrinologist, primary care clinician, registered dietitian, pharmacist, cardiologist, or qualified health provider. If you have chest pain, severe shortness of breath, fainting, stroke symptoms, severe dehydration, persistent vomiting, severe abdominal pain, confusion, or another emergency, seek urgent medical care right away.